Carolin Dorothea Strobl

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Gene Expression

Dendritic Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Roland Windisch, Sarah Soliman, Adrian Hoffmann, Linping Chen-Wichmann, Anna Danese, Sebastian Vosberg, Jimena Bravo, Sebastian Lutz, Christian Kellner, Alexander Fischer, Claudia Gebhard, Enric Redondo Monte, Luise Hartmann, Stephanie Schneider, Fabian Beier, Carolin Dorothea Strobl, Oliver Weigert, Matthias Peipp, Michael M Schündeln, Stefan H Stricker, Michael Rehli, Juergen Bernhagen, Andreas Humpe, Hannes Klump, Christian Brendel, Daniela S Krause, Philipp A Greif, Christian Wichmann
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Roland Windisch, Sarah Soliman, Adrian Hoffmann, Linping Chen-Wichmann, Anna Danese, Sebastian Vosberg, Jimena Bravo, Sebastian Lutz, Christian Kellner, Alexander Fischer, Claudia Gebhard, Enric Redondo Monte, Luise Hartmann, Stephanie Schneider, Fabian Beier, Carolin Dorothea Strobl, Oliver Weigert, Matthias Peipp, Michael M Schündeln, Stefan H Stricker, Michael Rehli, Juergen Bernhagen, Andreas Humpe, Hannes Klump, Christian Brendel, Daniela S Krause, Philipp A Greif, Christian Wichmann
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Roland Windisch, Sarah Soliman, Adrian Hoffmann, Linping Chen-Wichmann, Anna Danese, Sebastian Vosberg, Jimena Bravo, Sebastian Lutz, Christian Kellner, Alexander Fischer, Claudia Gebhard, Enric Redondo Monte, Luise Hartmann, Stephanie Schneider, Fabian Beier, Carolin Dorothea Strobl, Oliver Weigert, Matthias Peipp, Michael M Schündeln, Stefan H Stricker, Michael Rehli, Juergen Bernhagen, Andreas Humpe, Hannes Klump, Christian Brendel, Daniela S Krause, Philipp A Greif, Christian Wichmann
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Michael Mentz, William Keay, Carolin Dorothea Strobl, Martina Antoniolli, Louisa Adolph, Michael Heide, Axel Lechner, Sarah Haebe, Elisa V Osterode, Robert Kridel, Christoph Ziegenhain, Lucas Esteban Wange, Johannes Adrian Hildebrand, Tanaya Shree, Elisabeth Silkenstedt, Annette M Staiger, German Ott, Heike Horn, Monika Szczepanowski, Julia Richter, Ronald Levy, Andreas Rosenwald, Wolfgang Enard, Ursula Zimber-Strobl, Michael von Bergwelt-Baildon, Wolfgang Hiddemann, Wolfram Klapper, Marc Schmidt-Supprian, Martina Rudelius, Deepak Bararia, Verena Passerini, Oliver Weigert
PARP14 is a novel target in STAT6 mutant follicular lymphoma. Leukemia 36 (9) (2022)
Carolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, Simon Völkl, Katrin Peter, Katrin Singer, Martin Böttcher, Dimitrios Mougiakakos, Andreas Mackensen, Michael Aigner
Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Molecular cancer therapeutics 19 (2) (2019)